Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Bioxyne Limited ( (AU:BXN) ) is now available.
Bioxyne Limited has revised its Appendix 4C for the quarter ending 30 June 2025, correcting previous errors in reported cash flow figures. The updated report shows a net cash inflow from operating activities of A$1,554,000 and cash and cash equivalents at the quarter’s end totaling A$7,668,000. This correction provides a clearer picture of the company’s financial health and operational efficiency, potentially impacting stakeholder confidence and market perception positively.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its probiotic and immune health products, catering to a market that emphasizes health and well-being.
Average Trading Volume: 4,966,452
Technical Sentiment Signal: Buy
Current Market Cap: A$115.1M
See more data about BXN stock on TipRanks’ Stock Analysis page.